Long Live You

Welcome to Cambridge Nutraceuticals. Ou​r goal is to help people live longer, healthier lives.

W​e create supplements as they should be – easy to absorb, with proven clinical benefits. Our first product, ATERONON HEART+, was developed through £12 million in research funding and ​was clinically ​tested at Cambridge University Hospital NHS Foundation Trust to ​prove its effectiveness.

In 2015, we used this rigorous scientific approach and our partnerships with some of the world’s leading research institutions to ​create our FutureYou range of health supplements. Every FutureYou product is the focus of multiple clinical trials and is manufactured using ​the highest quality ingredients. TURMERIC+, the most popular of our Joint Health supplements and the focus of significant press coverage, is now supported by 30 published studies.

Based in Cambridge, ​the world-famous research hub, Cambridge Nutraceuticals was founded in 2012 and has grown ​rapidly, winning the confidence of customers, investors​ and internationally renowned research groups​. We sell direct-to-customer within the UK and reach international purchasers through our overseas distributors, with Australia being ​an especially important market.

We stay at the cutting edge of research, with an ong​oing programme for clinical evaluation of our innovative products, and we put people first: thanks to the health benefits of our supplements and the​ ​dedication to customer service shown by the FutureYou team, our customers have awarded us five stars for excellence on the independent review platform TrustPilot.

Featured Product

Cool-Joints-FutureYou

  COOL JOINTS+

     Highly bioavailable Boswellia serrata extract.

     Helps to keep joints cool and comfortable

     Increased bioavailability through phytosome technology

     See COOL JOINTS+ on the FutureYou website

 

 

 

Research and development supported by a high-profile medical board

Our medical advisory board includes some of the world’s leading scientists and doctors, including Professor Alf Lindberg, a former member of the Nobel Committee and Secretary of the Prize in Physiology or Medicine; Peter Kirkpatrick BSc MBCHB MSc FRCS, a leading Cambridge University vascular neurosurgeon; Dr Nicholas Shenker, a consultant rheumatologist and expert in chronic pain syndromes​; and ​Professor Michael Heinrich,​ Head of ​University College London's Centre for Pharmacognosy and Phytotherapy.